PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy
- Resource Type
- article
- Source
- Journal for ImmunoTherapy of Cancer, Vol 10, Iss 2 (2022)
- Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 2021-0035
2051-1426